Dr. Bernstein, a world leading authority in diabetes, is hosting a live internet broadcasts to answer your questions on diabetes. Diabetes 911 is setup to stop the complications of diabetes before it's an emergency. Here's a link to the page where you can submit your questions, to be answered on his next broadcast -- September 19, 2007.

Just a heads-up for The Diabetes Blog reading community - AOL has announced they will be retiring The Diabetes Blog on September 14, 2007. So this is a preemptive blog to get your calendar out, send yourself a reminder email titled: OPEN ON SEPTEMBER 19th!!!!

This will not be my last blog shared with you, all mighty readers of the blogosphere. I'm working to get my proverbial welcome mat in place to continue unfolding the mysteries of diabetes on LoveDiabetes.com. More to come...

Creator of Diabetes Health Magazine, Scott King, has been a type 1 diabetic for over 34 years. Needless to say, he knows diabetes, and he is doing a remarkable job of introducing cutting-edge treatments for diabetics. In the first Diabetes Health TV broadcast, he shared interviews from the recent AADE Conference. A really exciting product he featured is called Neuragen - a topical treatment for diabetes neuropathy.

With diabetes neuropathy, people experience pain due to damage to the peripheral nerves. Neuropathic pain is often characterized by burning sensations or shooting pain, or may occur as numbness or chronic itching. Clinical trials have shown Neuragen to be effective in 70% of patients for the pain associated with diabetes. The ingredients are pretty kosher, too. Neuragen is made of a proprietary blend of essential oils from special species of geranium, lavender, bergamot, eucalyptus, and tea tree.

The Neuragen rep was blunt when he described the effective nature of this all natural product - using more does not make it any more effective! You have to admire his refreshing honesty. But like I said upfront - if Scott King is willing to spend the time getting the scoop on this product - it's probably worth your time using it. For more interviews, checkot the full coverage of the AADE Conference on Diabetes Health TV!

Juan Domínguez-Bendala, Ph.D., is Director of Stem Cell Development for Translational Research at the Diabetes Research Institute. Once again, thanks to Gina and Jon at Diabetes Talkfest - you'll have the opportunity to chat live with Dr. Domínguez-Bendala on August 23rd at 9pm Eastern Standard Time.

Dr. Domínguez-Bendala is currently involved in several projects that focus on the use of embryonic stem cells to obtain pancreatic islets, in the hopes that these newly developed cells could one day be transplanted into patients with type I diabetes.

Join Dr. Domínguez-Bendala to discuss his work and ask questions pertaining to embryonic stem cell research. I know I'll be there, in true form, asking questions that I've been archiving for an event like this one!

Hear ye! Hear ye! I have an announcement to make. About 3 months ago, a committee formed to explore the possibility of creating a new conference series for adults with type 1 diabetes. Most conferences are currently geared towards all types of diabetes, but a group of us felt there should be more for the unique challenges that are posed to adults living with type 1.

With that in mind, we are conducting an interest study for the conference. Who would you like to see at the conference? Tell us what is missing from Type 1 diabetes (besides the obvious **cure**). This will help us with programming, as well as securing sponsorships for the event. Besides giving you all you want from the latest and greatest in type 1 diabetes - you have a chance to leave your mark on this revolutionary event. At the end of the survey, there is a question about creating a name for the conference. The committee will choose the winning name. The winner will receive an autographed copy of Know Your Numbers, by Amy Tenderich and Dr. Richard Jackson. The second and third places prizes are a Six Until Me mug and a Diabetes Mine mug, donated by Kerri Morrone and Amy Tenderich.

The survey closes on Friday, September 7, 2007 so don't miss your opportunity to voice your opinion. Take the survey today!!

If you're a daytime tv addict- the upcoming JDRF event might be worth your time and money. And don't worry about missing an episode of Days of our Lives. The event is being held on Saturday, August 25t!

Several stars of NBC's hit daytime drama series, Days of our Lives, are heading to Massachusetts on August 25 to support a charity event for the Juvenile Diabetes Research Foundation (JDRF). From 11am to 4pm, fans will get the opportunity to "meet and greet" their favorite Days of our Lives actors and actresses. There will also be photo opportunities and autograph sessions, as well as show novelties up for sale. However, food and beverages will not be served during the daytime reception, which has been priced at $80 per person.

Among the Days of our Lives stars that are slated to appear that night are James Scott (EJ Wells), Stephen Nichols (Steve "Patch" Johnson), Rachel Melvin (Chelsea Brady), Judi Evans (Adrienne Josephine Johnson Kiriakis) and Blake Berris (Nick Fallon). The JDRF charity event will be held at the Burlington Marriot. Fans who wish to attend the event can order tickets online. For those who will be coming from outside the Burlington area, a block of rooms have been set aside by the hotel specifically for the event. For room reservations, call 1-781-229-6565. Like sands through the hourglass... attend the fundraising event to enjoy the stars from Days of our Lives!

Touted by Tiger Woods and Phil Mickelson as one of the most well-thought-of players on tour, Scott Verplank has negotiated his Type 1 diabetes all the way up the rankings of the PGA tour.

Verplank diabetes began when he was 9 years old. The off-limits list included sports, but Verplank didn't listen to that one. He was a phenom, winning the 1985 Western Open as a senior at Oklahoma State. It had been 29 years since an amateur won a PGA event. A couple dozen more victories appeared likely. Nobody could see what trouble diabetes would cause.

Verplank does not let diabetes interrupt his game. Checking his blood sugar every few holes and walking all 18 - the inconvenience of diabetes will not sabotage his love of the game. Verplank doesn't consider himself a role model. He categorizes himself as just a regular guy. Everybody faces obstacles, and he's merely managing the challenges of everyday life just like everybody else. Although Scott's feather is the fact he's a pro golfer -- one of the top players in the world!!

The Juvenile Diabetes Research Foundation Capitol Chapter has become the only JDRF chapter in the country to put a new spin on fundraising. And what better place to do it than Washington? The Chapter is currently planning the second annual Spin to Win fundraiser for next fall.

A proven success with JDRF's Canadian chapter, it is the organization's newest event -- an innovative, high-energy, outdoor event where participants from a variety of local industries pedal to a fast-paced musical beat for 8 minutes in a race to see who can rack up the most mileage and the most money for diabetes research. Each spinner is asked to raise at least $150.

Last year's inaugural event raised more than $75,000 and members of Congress, athletes, and TV personalities were among the participants. The Chapter is looking to double the amount raised this year.

This year's fundraiser will take place Thursday, October 18 at the old DC Convention Center site and involve five-person teams from the Washington business community who have raised money for a cure for diabetes. Visit the Spin to Win web page or call the JDRF office at 202.465.4122 for more information about the 2007 Spin to Win.

Did anybody catch the first ever YouTube democratic debate last week? It was cosponsored by CNN and the cool thing about it was this: all the questions came in from Americans like you and me. Turns out two of the candidates spoke out on behalf of diabetes. Here's what they had to say...

Governor Richardson mentioned the fact that 33% of Medicare is wrapped up in diabetes costs. He suggests, "Let's have major prevention programs, and also ways that we can ensure that we find a cure." He still has not announced a plan to ensure a cure. But if he does - I'm willing to bet all of his campaign funding from Big Pharma might mysteriously disappear.

The other candidate addressing diabetes was Senator Chris Dodd of Connecticut. Dodd's promise came after from a woman's question about stem cell research. Somehow the senator was able to plug an endeavor to "deal with diabetes". However, much like Governor Richardson - he has yet to announce a plan to cure. Politics as usual. Stay tuned for the LIVE Republican Debate on September 17th.

Dr. Faustman's lab is currently collecting blood samples from individuals with established Type 1 diabetes. These samples are being used to quantify the number of autoreactive T-cells and develop the adequate dosage for Phase 1 of human trials to cure Type 1 diabetes.

The research has been presented and the NIH confirmed it. By reeducating the confused T-cells and instructing them not to attack healthy islets, an apparent cure of established type 1 diabetes in non-obese diabetic mice is possible. Now, Dr. Faustman is collecting human samples to bestow the same cure for diabetes in humans.

If you wish to be a part of this revolutionary event for curing Type 1 diabetes, please contact the Clinical Coordinator or call Dr. Faustman's lab at (617) 726-4084. Each participant is asked to bring a control person along with them - an unrelated person without Type 1 diabetes or another autoimmune disease. Diabetic or not - you can be a part of history in curing Type 1 diabetes!

Meet the Face of Change is a photo exhibit owned by Novo Nordisk featuring YOU -- the face of change. Change for what, I asked? Well, it seems Novo would like to change your opinion of the barriers to insulin treatment for Type 2 diabetics. The common belief of insulin treatment for Type 2 diabetes is that it is the point of no return. Why? First instincts are usually correct.

Studies have shown that Type 2 diabetics injecting insulin create insulin antibodies (IAA). Type 1 diabetics have these antibodies upon diagnosis. Type 1 diabetes was also formerly referred to as insulin-dependent diabetes. Insulin antibodies (IAA) develop and attack the natural insulin produced, resulting in insulin dependence. Type 2 diabetics do not have the same level of IAA. Once they begin injecting insulin that looks like human insulin (the kind Novo makes) - you run the risk of developing IAA. The use of animal-insulins did not cause the development of IAA to the same extent. If you plan to start injecting insulin - ask your doctor if he will check you for IAA. As a Type 2 diabetic, you DO NOT have to become an insulin-dependent diabetic.

I asked Novo to explain what Meet the Face of Change is about. What are they trying to change? The response I received from Nov explains their wishes to strengthen the drive of their business, among other core values. Now I ask you - how do you drive a business that sells insulin? Sell more insulin. For the 16 million Type 2s not yet in this lineup- please consider if insulin-dependent diabetes is the face you want to meet. Don't add insulin to injury. It may not be the path of least resistance, but cut back on simple sugars, increase fiber consumption, and take a walk after dinner. Meet the face of change by putting your best foot forward, not your face on a campaign for vulture capitalism.

DiabeCell has successfully been transplanted into the first type I diabetes patient. This trial is testing its efficacy and safety in controlling the dangerous blood glucose levels to prevent long-term secondary complications of type I diabetes.

Living Cell Technologies has announced the successful transplant into the first of six type I (insulin dependent) diabetic patients in a world-first human clinical trial using DiabeCell. Patients in the trial will receive two low doses of the pig islet cells every six months over a 12 month period, followed by a further 12 month study, evaluating the benefits. Recipients in this first trial are given the lowest clinically effective dose to demonstrate safety. The dosing is repeated for additional clinical benefit. The company hopes to commercialize the product for general use by 2012.

DiabeCell is a pig pancreatic islet cell product that secretes insulin in response to the patient's blood glucose levels. People with type I diabetes are not able to produce their own insulin because their pancreas cells are not functioning. DiabeCell has been uniquely developed with a gel that forms a tiny capsule around the cells. This prevents the patient's immune system from destroying the transplant and does not require immunosuppressive drugs. Think of DiabeCell as bubble wrap for islets -- cool, right?

The B.A.D Ride was born ten years ago in Southern California. B.A.D as in Bikers Against Diabetes. Rip Rose, a biker and photojournalist for Easyriders, wanted to bring the biker nation together in the fight against diabetes. Today, that dream is a reality.

On Sunday morning, June 10th, nearly two dozen Harley-Davidson motorcycles roared to life, heading out to Oak Canyon Park in Irvine, where they were joined by hundreds of other riders from Southern California at a fair with bands, food, vendors and a ride-in bike show. Sunday's event marked the ride's 10th anniversary. Rip's B.A.D Ride partners with the American Diabetes Association, and 80% of the money raised goes to diabetes research.

This story goes out to my dad, Bizzle. He's a HOG (a member of the Harley-Davidson Owners Group). He's told me they are the nicest people you will ever meet and that is why he enjoys his open road adventures. It looks like he's right. I think he would love to join a Rip's B.A.D Ride. Those of you HOGs interested in upcoming rides for diabetes, checkout the schedule. Thanks to all those who fire up for the sake of diabetes!

As my parents explained it to me, when your child is diagnosed with diabetes you are slapped in the face with a shocking revelation: we can't fix this! However a blessing in disguise was bestowed upon Dylan Fossella, an 11- year-old boy who also happens to be the son of Vito Fossella, a Congressman from Staten Island.

Dylan Fossella, was just five years old when he was diagnosed with type 1 diabetes. He will be one of 150 other children and teenagers living with type 1 diabetes from across the country heading to D.C. on behalf of the Juvenile Diabetes Research Foundation. They will speak to lawmakers to encourage funding toward a cure. To earn the trip to Washington, he had to write a letter to his local Congressman, who happens to be his dad. The message Dylan most wants his dad and other politicians to hear is the same message I promoted when I visited Washing D.C in the 1990s with the American Diabetes Association: find a cure in my lifetime, please.

Over the years, many people have regarded diabetes as a disease that's manageable. True -- but that's easier said than done. For kids like Dylan that means checking your sugar about four times a day (or more) and upwards of six insulin shots a day. As a personal reflection -- I consider myself lucky to be one of the 13,000 children chosen in 1985 for juvenile diabetes. Here I am 22 years later, blogging on behalf of Dylan. It is my hope that he and his family can make a difference for all of us wishing for that cure. Have a great time in D.C, Dylan. It'll be the memory of a lifetime!

House Calls, a popular newsletter written by the prestigious Dr. Inglis, highlights a very important question in light of the Avandia mishap: how many other potential whistle-blowers are out there who have been silenced into submission before the Big Pharma vultures?

A medical expert testified that he agreed to sign a statement that was meant to appease the company's investors. This is not the type of behavior anyone should expect or dismiss of a doctor, entrusted with a patient's life. In his defense, he did forward a letter with his concerns to the FDA, which means they also were aware of the same threat. This same doctor is the President-elect for none other than the American Diabetes Association. Isn't that special? The ADA -- my friend, my confidant, my utter supporter of the C-peptide crusade ... sense the sarcasm? So much for advocacy, when the president-elect of this organization so willingly swept those safety concerns under the table, when he should have been throwing a tantrum on top of it! And all over the threat of litigation from a drug company more concerned about its investors than patients.

The closing comments in Dr. Inglis' newsletter say it all: There are so many vultures out there waiting to pick the bones of the American public, it disgusts me. This example goes to show why I always recommend to you -- and to all of my patients -- that you always question everything when it comes to your health. I don't care if it's your doctor you've had for 50 years or one of these nonprofit organizations -- give them all hell.